Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine

European Journal of Endocrinology

Volumn 142, Issue 2, 2000, Pages 157-163

  Broglio, Fabio ^a   Benso, Andrea ^a   Gottero, Cristina ^a   Di Vito, Lidia ^a   Aimaretti, Gianluca ^a   Fubini, Alberto ^a   Arvat, Emanuela ^a   Bobbio, Marco ^a   Ghigo, Ezio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GONADORELIN; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; FLUSHING; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HEART DILATATION; HEART MUSCLE; HORMONE RESISTANCE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0034006309     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420157     Document Type: Article

References (54)

1. Isgaard J, Nilsson A, Vilkman K & Isaksson OGP. Growth hormone regulates the level of insulin-like growth factor mRNA in rat skeletal muscle. Journal of Endocrinology 1989 120 107-112.
2. Mayoux E, Ventura-Clapier R, Timsit J, Béhar-Cohen F, Hoffmann C & Mercadier JJ. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circulation Research 1993 72 57-64.
3. Saccà L, Cittadini A & Fazio S. Growth hormone and the heart. Endocrine Reviews 1994 15 555-573.
4. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER & Eppenberger HM. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle α-actin of adult cardiomyocytes. Proceedings of the National Academy of Science of the USA 1994 91 1686-1690.
5. Freestone NS, Ribaric S & Mason WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Molecular and Cellular Biochemistry 1996 163-164 223-229.
6. 2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart. Circulation Research 1996 79 227-236.
7. Cittadini A, Stromer H, Katz SE, Clark R, Moses A, Morgan J et al. Differential cardiac effects of growth hormone and insulin-like growth factor I in the rat. A combined in vivo and in vitro evaluation. Circulation 1996 93 800-809.
8. Redaelli G, Malhotra A, Li B, Li P, Sonnenblick EH, Hofmann PA et al. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circulation Research 1998 82 594-603.
9. Hirsch EZ, Sloman JG & Martin FI. Cardiac function in acromegaly. American Journal of Medicine 1969 57 823-829.
10. Mather HM, Boyd MJ & Jenkins JS. Heart size and function in acromegaly. British Heart Journal 1979 41 697-701.
11. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG & Foale RA. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. British Heart Journal 1992 67 92-96.
12. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D et al. Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism 1993 77 1671-1676.
13. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B et al. Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. European Heart Journal 1993 14 26-33.
14. De Boer H, Blok GJ & Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews 1995 16 63-86.
15. Salomon F, Cuneo RC, Hesp R & Sonksen P. The effect of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine 1989 321 1797-1803.
16. Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D et al. Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1993 77 1658-1661.
17. Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E et al. Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement. American Journal of Physiology 1994 267 E219-K225.
18. Caidahl K, Eden S & Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clinical Endocrinology 1994 40 393-400.
19. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U & Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. Journal of Clinical Endocrinology and Metabolism 1995 80 659-666.
20. Fazio S, Biondi B, Sabatini D, Cuocolo A, Tommaselli AP, Lombardi G et al. Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy. Journal of Clinical Endocrinology and Metabolism 1996 81 887-890.
21. Johannsson G, Bengtsson BA, Andersson B, Isgaard J & Caidahl K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients. Clinical Endocrinology 1996 45 305-314.
22. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. New England Journal of Medicine 1996 334 809-814.
23. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R et al. Randomized, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998 351 1233-1237.
24. Giustina A, Lorusso R, Borghetti V, Bugari G, Misitano V & Alfieri O. Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. American Heart Journal 1996 131 620-622.
25. Mangieri E, Tosti-Croce C, Tanzilli G, Barillà F, Nardi M, Poggi M et al. Impairment of growth hormone/insulin-like growth factor-I axis in normopituitaric patients with biventricular cardiac failure and hepatic stasis. Cardiologia 1996 41 449-453.
26. Volterrani M, Desenzani P, Lorusso R, d'Aloia A, Manelli F & Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1997 359 1067-1068.
27. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997 96 526-534.
28. Giustina A, Volterrani M, Desenzani P, Lorusso R, Manelli F, Perini P et al. Endocrine predictors of the acute hemodynamic effects of growth hormone in patients with severe heart failure. 79th Annual Meeting of The Endocrine Society, Minneapolis, 11-14 June, 1997 p 93.
29. Pflaum CD, Anker SD, Leyva F, Rauchhaus M, Coats AJS & Strasburger CJ. Lack of suppression of growth hormone (GH) levels by glucose in patients with cardiac cachexia: further evidence for GH resistance. 80th Annual Meeting of The Endocrine Society, New Orleans, 24-27 June, 1998, p 163.
30. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA et al. Deficient insulin-like growth factor 1 in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. Journal of the American College of Cardiology 1998 32 393-397.
31. Broglio F, Fubini A, Morello M, Arvat E, Aimaretti G, Gianotti L et al. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clinical Endocrinology 1999 50 417-430.
32. Ghigo E. Neurotransmitter control of growth hormone secretion. In Regulation of Growth Hormone and Somatic Growth, pp 103-136. Ed. LF De la Cruz. Amsterdam: Elsevier Science Publishers, 1992.
33. Casanueva FF. Physiology of growth hormone secretion and action. Endocrinology and Metabolism Clinics of North America 1992 21 483-517.
34. Ghigo E. Neural control of GH secretion in aged humans. In Growth Hormone and Somatomedins during Lifespan, pp 275-287. Eds EE Muller, D Cocchi & V Locatelli. Berlin: Springer, 1994.
35. Jaffe CA, DeMott-Friberg R & Barkan AL. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli. Journal of Clinical Investigation 1996 97 934-940.
36. Ghigo E, Aimaretti G, Gianotti L, Bellone J, Arvat E & Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology 1996 134 352-356.
37. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. Journal of Clinical Endocrinology and Metabolism 1996 81 3323-3327.
38. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. Journal of Clinical Endocrinology and Metabolism 1998 83 1615-1618.
39. Sahn DJ, De Maria A, Kisslo J & Weyman A. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978 58 1072-1083.
40. Schiller NB, Shahn PM, Crawford M, De Maria A, Devereux R, Feigenbaum H et al. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography. Journal of the American Society of Echocardiography 1989 2 358-367.
41. Ghigo E, Arvat E, Muccioli G & Camanni F. Growth hormone-peptides. European Journal of Endocrinology 1997 136 445-460.
42. Ghigo E, Arvat E, Valente F, Nicolosi M, Boffano GM, Procopio M et al. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology 1991 54 291-294.
43. Ghigo E, Miola C, Aimaretti G, Valenle F, Procopio M, Arvat E et al. Arginine abolishes the inhibitory effect of glucose on the GH response to GHRH in man. Metabolism 1992 41 1000-1003.
44. Maccario M, Procopio M, Loche S, Cappa M, Martina V, Camanni F et al. Interaction of free fatty acids and arginine on growth hormone secretion in man. Metabolism 1994 43 223-226.
45. Ghigo E, Goffi S, Nicolosi M, Arvat E, Valente F, Mazza E et al. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Journal of Clinical Endocrinology and Metabolism 1990 71 874-876.
46. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Summary statement of the Growth Hormone Research Society workshop on adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
47. Thorner MO, Bengtsson BA, Ho KY, Albertsson-Wikland K, Christiansen JS, Faglia G et al. Diagnosis of growth hormone deficiency in adults. Journal of Clinical Endocrinology and Metabolism 1995 80 3097-3098.
48. Arvat E, Bellone J, Procopio M, Grottoli S, Maccario M, Camanni F et al. Neuroregulation of growth hormone secretion in man. Developmental Brain Dysfunction 1996 9 93-99.
49. Ghigo E, Arvat E, Gianotti L, Ramunni J, Di Vito L. Maccagno B et al. Human aging and the GH/IGF-I axis. Journal of Pediatric Endocrinology and Metabolism 1996 9 271-278.
50. Van Veldhuisen DJ, Boomsma F, De Kam PJ, Man in't Veld AJ, Crijns HJ, Hampton JR et al. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure. European Heart Journal 1998 19 753-760.
51. Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H & Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995 92 1801-1807.
52. Sigurdsson A. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure with special reference to treatment with angiotensin converting enzyme inhibitors. Blood Pressure Supplement 1995 1 1-45.
53. Gheorghiade M & Ferguson D. Digoxin. A neurohormonal modulator in heart failure? Circulation 1991 84 2181-2186.
54. Diez J & Laviades C. Insulin-like growth factor-I and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. Journal of Hypertension 1994 12 S31-S36.